Evidence map›Paper›PMID 26222078›Full record

ReviewCancer journal (Sudbury, Mass.)

The Contribution of Angiogenesis to the Process of Metastasis.

Diane R Bielenberg, Bruce R Zetter

Abstract readReview
In one paragraph

Review in Cancer journal (Sudbury, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 279 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
279citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

279 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Linking tumour angiogenesis and tumour immunity.Nature reviews. Immunology · 2026
    Review
  18. Article
  19. Article
  20. Article

219 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Diane R BielenbergFrom the Department of Surgery, Harvard Medical School, Vascular Biology Program, Boston Children's Hospital, Boston, MA.
Bruce R Zetter

Funding

Modulators of Prostate Cancer MetastasisR01CA037393 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZETTER, BRUCE R · 1985 to 2015
$2.6M
Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma ProgressionR21CA155728 · NCI · BOSTON CHILDREN'S HOSPITAL · PI BIELENBERG, DIANE RENEE · 2011 to 2012
$416k
NCI NIH HHS R01 CA037393NCI NIH HHS R01CA037393NCI NIH HHS R21 CA155728NCI NIH HHS R21CA155728 (
6 · The paper itself

Abstract

The role of angiogenesis in tumor growth has been studied continuously for over 45 years. It is now appreciated that angiogenesis is also essential for the dissemination and establishment of tumor metastases. In this review, we focus on the role of angiogenesis as a necessity for the escape of tumor cells into the bloodstream and for the establishment of metastatic colonies in secondary sites. We also discuss the role of tumor lymphangiogenesis as a means of dissemination of lymphatic metastases. Appropriate combination therapies may be used in the future to both prevent and treat metastatic disease through the rational use of antiangiogenic and antilymphangiogenic therapies in ways that are informed by the current and future work in the field.

Indexed as

LymphangiogenesisLymphatic MetastasisNeoplasm MetastasisAngiogenesis InhibitorsEpithelial-Mesenchymal TransitionHumansNeoplasmsNeovascularization, PathologicAngiogenesis Inhibitors

Identifiers

PMID26222078
PMCPMC4670555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.